Boston University is a world leader in the study of infectious diseases. Our National Emerging Infectious Diseases Laboratories (NEIDL) is part of a national, cutting-edge network of secure facilities researching everything from COVID to the Ebola virus to HIV with the goal of understanding, controlling, and eradicating them.
Cases of the highly contagious viral disease have already surpassed those of last year. We […]
Global partnership led by BU law professor has now given $452.6 million in funding to […]
BU’s New England Centenarian Study delves into the lives of superagers to better understand why […]
A BU infectious diseases expert on how the current surge compares to past pandemic years, […]
BU Technology Development’s 2023 Ignition Awards help researchers transform their ideas into life-changing products and […]
Winners of 2023 interdisciplinary research fund grants aim to improve study of lung disease and […]
TB is the world’s second-deadliest infectious disease, behind COVID-19. A new BU-led study shows how […]
Nahid Bhadelia has returned to BU after helping lead the Biden administration’s COVID-19 pandemic response […]